Skip to main content
. 2012 Nov 14;7(11):e49304. doi: 10.1371/journal.pone.0049304

Table 2. Characterization of mitoxantrone-loaded nanoparticles.

Sample Drug/carrier (w/w)a Diameter (nm)b Encapsulation (%)c Loading capacity (%)d
CHP 1/10 168.6±3.3 58.6±3.14 7.12±0.24
CHCP 1/10 192.7±4.2 50.8±2.26 6.14±0.16
a

Mitoxantrone/CHP or CHCP NPs (mg/mg).

b

Size and size distribution (mean value ± S.D) determined by dynamic light scattering with three times.

c

Encapsulation efficiency (mean value ± S.D) determined by UV spectrophotometry at 608 nm with three times.

d

Loading capacity of NPs (mean value ± S.D) determined by UV spectrophotometry at 608 nm with three times.